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OBJECTIVES: To assess the expression of decidual natural killer (dNK) cells and their cytokines in twin
pregnancies with preeclampsia.
METHODS: This was a prospective case-control study. The inclusion criteria were diamniotic (monochorionic or
dichorionic) twin pregnancies in the third trimester with negative serological results for infectious diseases;
absence of major fetal abnormalities or twin-twin transfusion syndrome; and no history of administration of
corticosteroids in this pregnancy. The control group (CG) included uncomplicated twin pregnancies, and the
preeclampsia group (PEG) included twin gestations with clinical and laboratory confirmation of the disease
according to well-established criteria. Samples of the decidua were obtained and analyzed by immunohis-
tochemistry for the expression of dNK cells and interleukins (ILs) 10, 12 and 15. In addition, maternal serum
samples were collected to determine the levels of these interleukins.
RESULTS: Thirty twin pregnancies were selected: 20 in the control group (CG) and 10 in the preeclampsia group
(PEG). The PEG showed strong placental immunostaining for IL-15 (p=0.001) and high maternal serum levels of
IL-10 (22.7 vs. 11.9 pg/mL, p=0.024) and IL-15 (15.9 vs. 7.4 pg/mL, p=0.024).
CONCLUSION: A higher maternal serum concentration of both pro- and anti-inflammatory factors was observed
in the twin pregnancies in the PEG. However, no difference in placental expression of IL-10 was found between
the groups. These findings may suggest that maternal attempts to balance these interleukins were not sufficient
to cause a placental response, and this failure may contribute to the development of preeclampsia.
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’ INTRODUCTION
Preeclampsia (PE) is the leading cause of maternal and
perinatal morbidity and mortality worldwide (1,2). Although
the underlying pathophysiology of PE remains partially
unknown, relevant characteristics of this disease include
maternal endothelial dysfunction and inflammatory imbal-
ance; most recently, chronic immune activation was also noted
(3-5). Importantly, the definitive solution for PE is the delivery
of the placenta (6), leading to investigations related to the
dynamic interactions involving the maternal-fetal interface.
Interest has been focused on the role of decidual natural
killer (dNK) cells, not only for their numerical importance as
one of the main cell types present in early maternal decidua
but also because of their unique functional properties, which
may represent novel immunotherapeutic opportunities (7,8).
Controversy still exists regarding the behavior of dNK cells in
PE: whereas some studies have demonstrated higher concen-
trations of this cell type (9,10), others have observed lower
expression of dNK cells in singleton gestations with PE (11-13).
Additionally, several studies have investigated the profiles
of dNK regulatory cytokines in the pathophysiology of PE.
These substances are produced in the maternal-fetal interface
and are responsible for complex interactions between the
distinct cell types present at the decidua, contributing to
trophoblastic invasion (14). Among these cytokines, there
is strong evidence in the literature of the crucial role of
interleukins (IL) 10, 12 and 15 as important regulators of
dNK cell functions (5,8).
Patients with PE tend toward an inflammatory profile, as
demonstrated by increased maternal circulating levels of IL-
15 (10,15). Hromadnikova et al. recently demonstrated that
this interleukin could increase the production of interferon-
gamma (IFN-g), a substance with known deleterious effects
on trophoblastic invasion (16). In addition, IFN-g acts on
dNK cells by means of a feedback mechanism, promoting the
production and release of IL-12, which is the main dNK cell
stimulating factor (17). Therefore, this cascade may perpe-
tuate a harmful inflammatory cycle.DOI: 10.6061/clinics/2019/e1200
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Furthermore, some authors have observed lower placental
expression of IL-10 in cases of PE (9,18). This cytokine plays
an important anti-inflammatory role and may prevent poten-
tial obstruction of angiogenesis and trophoblastic invasion,
thus protecting against PE development (19). In addition to
the protective role of IL-10 in inflammation, Kalkunte et al.
(20) proposed that IL-10 may function as a vital bridge
that links immunity, placental angiogenesis, and hypoxia at
the maternal-fetal interface. However, the data relating to
maternal circulating levels of IL-10 in PE remain inconclusive
(21,22).
Notably, however, all these studies were performed in
singleton pregnancies, and in our literature search, we did
not find studies investigating dNK cells in twin pregnancies
with PE. Considering that the incidence of PE is higher in twin
gestations and occurs in more severe forms in this group (23),
we sought to investigate the pathophysiology of this disease
in twin pregnancies through observation of dNK cells and
their regulatory cytokines.
’ MATERIALS AND METHODS
Study Design
This was a prospective case-control study, conducted in
the Multiple Pregnancy Unit of Department of Obstetrics and
Gynecology of São Paulo University Medical School, from
July 2015 to June 2017. The study protocol was approved by
the University Ethical Committee (46741815.8.0000.0068).
The inclusion criteria used were as follows: diamniotic
(monochorionic or dichorionic) twin pregnancies in the third
trimester with negative serological results for infectious
diseases; absence of major fetal abnormalities or twin-twin
transfusion syndrome; and no history of administration of
corticosteroids in this pregnancy. The exclusion criteria used
were rupture of amniotic membranes for a prolonged time
(greater than 12 hours); failure to obtain fragments of
placenta decidua after delivery; failure to obtain laboratory
results; or postnatal diagnosis of congenital anomaly or
genetic syndrome in at least one of the newborns.
The control group (CG) included uncomplicated twin
pregnancies without any previous or current clinical condi-
tions. The preeclampsia group (PEG) included twin gesta-
tions with no other previous or current clinical conditions,
except clinical and laboratory confirmation of preeclampsia
according to well-established criteria (1): systolic blood pres-
sure of 140 mmHg or more or diastolic blood pressure of
90 mmHg or more on two occasions, at least 4 hours apart,
after 20 weeks of gestation in a woman with a previously
normal blood pressure, associated with proteinuria (300 mg or
more per 24 hour urine collection). In the absence of
proteinuria, new-onset hypertension with thrombocytopenia,
renal insufficiency, impaired liver function, pulmonary edema,
new-onset headache or visual symptoms also indicated PE (1).
Calculation of Sample Size
Since we were not able to find any studies in the literature
describing the expression of dNK cells or their regulatory
interleukins in twin pregnancies with PE, the calculation of
sample size was based on the study of Olusi et al. (14). In this
study, the authors determined the maternal serum concen-
trations of interleukins in singleton pregnancies with and
without PE. The values for IL-10 were PE group: 93.2±24.1
pg/mL; Control group: 31.1±7.0 pg/mL. Assuming the
same difference observed by Olusi et al., we would require
five patients in each group (significant level, 5%; power,
80%). In order to reduce statistical bias, the number of cases
used was duplicated. The patients were then matched by
chorionicity in a proportion of two control cases for each case
in the study group. For all experiments all cases and controls
were considered.
Sample Collection
Up to seven days before delivery, 10 mL of maternal blood
sample was collected by peripheral venous puncture and
placed in a tube with EDTA (ethylenediaminetetraacetic
acid) and in a dry tube, which were promptly sent to the
laboratory for processing: serum and plasma were obtained
by centrifugation and stored at –80oC until further analysis.
Placental tissue was taken immediately after delivery, and
slices of the maternal decidual region were obtained, fixed in
formalin, and paraffin embedded. The placental paraffin-
embedded sections (5.0 mm) were deparaffinized in xylene
and rehydrated in increasing concentrations of alcohol and
distilled water. For heat-induced antigenic retrieval, the
sections were placed in 10 mM boiling citrate buffer (pH 6.0)
in an electric cooker for 30 min and allowed to cool for
15 min at room temperature (RT). Slides were rinsed in running
tap water and 3 changes of phosphate buffered saline (PBS)
for 5 min each. Endogenous peroxidase was blocked by
incubating the slides with 3 changes of 3% H2O2 for 20 min
each at RT in the dark. The placental tissues were incubated
with primary antibodies anti-CD56 (cluster of differentiation
of dNK cells clone RNL-1; Abcam, Cambridge, UK; dilution
of 1:75), anti-IL-10 (Abcam, Cambridge, UK; dilution of
1:200), anti-IL-12p40 (Abcam, Cambridge, UK; dilution of
1:150) and anti-IL-15 (Abcam, Cambridge, UK; dilution
of 1:300) overnight at 4oC. The primary antibody was washed
off, and the slides were rinsed 3 times in PBS and then
incubated with the secondary antibody (Novolink Polymer,
Leica Biosystems Newcastle Ltd.). After rinsing in PBS, the
reactions were developed by using the substrate-chromogen
DAB (Sigma Chemical Corporation, St. Louis, Missouri, USA).
All incubations were performed in a humidity chamber.
Placental samples from the CG and PEG were processed
simultaneously. The nuclei were counterstained with hema-
toxylin, and the slides were dehydrated in a series of ethanol
dilutions and washed in xylene before putting on coverslips
with Tissue Tek Glas Mounting Media (Sakura Finetek,
Netherlands). For negative controls, the primary antibody
was omitted.
Morphometric Placental Analysis
Morphometric analyses of the placentas were performed
as previously described (24). Briefly, the decidual space was
described by analyzing the hematoxylin-stained sections of
the placenta. For each section, five areas of the decidual
region were randomly selected for the image acquisition
(400x magnification) by using a Leica microscope (Leica
Biosystems, Germany) and LAS image acquisition software.
The images were analyzed using the image processing and
analysis program ImageJ (NIH, Bethesda, MA, USA). The
images were given a color threshold to cover the area
corresponding to the decidual region. The percentage of
coverage for each antibody was calculated as the ratio
between the number of pixels covered by the area defined by
the threshold and the total number of pixels in the image,
multiplied by 100, and compared between the groups.
2
dNK cells expression in twins with preeclampsia
Agra IKR et al.
CLINICS 2019;74:e1200
Serum Analysis
Serum was analyzed in duplicates for IL-10, IL-12 and
IL-15 by means of a commercial Milliplexs kit using
Luminexs xMAPs technology from EMD Millipore (Merck
Millipore Co., Germany).
Statistical Analysis
Data were analyzed using SPSS software (IBM SPSS
Statistics for Windows, Version 20.0. IBM Corp., Armonk,
NY). Baseline characteristics described were related to mater-
nal characteristics (age, color, educational level, body mass
index and habits), pregnancy and childbirth aspects (parity,
blood pressure levels, mode of delivery, time of membrane
rupture and preeclampsia specific tests) and neonatal vari-
ables (sex, birthweight and Apgar index), followed by immu-
nohistochemical and maternal serum results. Continuous
data were expressed as the median. To perform comparisons
between groups, the Mann–Whitney U-test was used for
quantitative variables, and Fisher’s exact test was used for
qualitative variables. A value of po0.05 was considered
significant.
’ RESULTS
During the study period, 34 eligible pregnant women with
twin pregnancies consented to participate: 24 with uncom-
plicated gestations and 10 with confirmed PE diagnoses.
Four patients in the CG were excluded because fragments of
placental decidua could not be obtained after delivery.
Therefore, 30 pregnant women remained: 20 in the CG
(14 dichorionic – DC – and six monochorionic – MC) and 10
in the PEG (7 DC and 3 MC).
The baseline characteristics were similar between the two
groups (Table 1). Although a higher proportion of patients
defined as non-white (60% vs. 35%) and nulliparous (80% vs.
40%) were present in the PEG, the difference was not
statistically significant (p=0.255 and 0.058, respectively).
In the PEG, 70% of the cases were classified as severe due
to blood pressure 4160/110 mmHg on more than one
occasion, according to the American College of Obstetricians
and Gynecologists (ACOG) criteria (1). Among those cases,
we observed only one event of placental abruption at
31 weeks. Additionally, no cases of hemolysis, elevated liver
enzymes, and low platelet count (HELLP) syndrome were
diagnosed in the PEG.
In the immunohistochemical analysis, we observed higher
expression of IL-15 in the PEG – 34.82% (19.07-47.37) versus
6.09% (1.62-16.33), p=0.001 – with no significant difference
between the groups with respect to the placental expression
of dNK cells or the other factors: for CD56 expression, 0.11%
(0.04-0.35) in the PEG vs. 0.15% (0.04-0.56) in the CG,
p=0.231; for IL-10, 4.55% (1.87-12.0) in the PEG vs. 3.10%
(1.12-14.82) in the CG, p=0.231, and for IL-12, 6.76% (1.66-
17.59) in the PEG vs. 2.17% (0.81-11.57) in the CG (Figure 1).
Table 1 - Baseline characteristics of study population.
Control Group (n=20) Preeclampsia Group (n=10) p
Maternal characteristics
Age, yearsa 30 (19-40) 25 (16-48) 0.328
Non-white, n (%)b 7 (35) 6 (60) 0.255
Educational level, yearsa 11 (6-14) 8 (6-14) 0.502
BMI, kg/m2 a 27.2 (21.6-47.3) 30.7 (22.0-33.5) 0.397
Smoking, n (%)b 3 (15) 0 (0) 0.532
Pregnancy characteristics
Nulliparous, n (%)b 8 (40) 8 (80) 0.058
Spontaneous gestation, n (%)b 17 (85) 8 (80) 0.999
24h proteinuria, grams NA 1.07 (0.32-7.9) NA
Mean BP, mmHga 79.1 (68-93.3) 126.6 (106.6-140) 0.0001
GA PE diagnosis, weeks NA 34.3 (30.1-37.0) NA
GA maternal blood sample, weeksa 36.9 (35.1-37.5) 36.5 (31.0-37.0) 0.186
GA at delivery, weeksa 37.4 (35.1-38.0) 36.7 (31.7-37.2) 0.131
Delivery by cesarean, n (%)b 13 (65) 8 (80) 0.675
Time of membrane rupture, hoursa 5.7 (4-8) 8.0 (4-12) 0.423
Placental total weight, gramsa 852.5 (515-1278) 755.0 (570-1030) 0.307
Neonatal characteristics
Male, n (%)b 22 (55) 12 (60) 0.887
Birthweight, kga 2.56 (1,56-3,15) 2.43 (1.69-3.16) 0.760
Apgar score o7 at 5 min, n (%)b 0 (0) 0 (0) 0.999
Birthweight o10th percentile, n/N (%)b 5/40 (12.5) 1/20 (5) 0.653
Data described as the median (range). aMann-Whitney test. bFisher’s exact test. BMI = body mass index; BP = blood pressure at time of diagnosis for
preeclampsia group and at admission for control group; GA = gestational age; NA = not applicable; PE = preeclampsia.
Figure 1 - Placental expression of dNK cells and their regulatory
interleukins. Percentage of stained area delimited by morpho-
metric analysis. Data described as median (range). CD56 = cluster
of differentiation of dNK cells. Mann-Whitney test, po0.05.
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Additionally, we repeated the analysis after removing cases
with neonatal birthweight o10th percentile (four in the CG
and one in the PEG). The results remained unchanged, with a
significant difference between the groups found only for
the decidual expression of IL-15 (6.09 vs. 37.62, p=0.001).
Figure 2 compares the morphometric immunohistochemical
analyses of these groups.
The maternal serum analysis demonstrated higher levels
of IL-10 and IL-15 in the PEG – 22.7 (4.6-46.4 pg/mL) vs. 11.9
(2.1-35.5 pg/mL) for IL-10 and 15.9 (4.0-24.2 pg/mL) vs. 7.4
(0.8-25.8 pg/mL) for IL-15, p=0.024 – and no significant
difference between the two groups for the expression of IL-
12 – 102.5 (2.8-251.8 pg/mL) in the PEG vs. 61.5 (2.8-253.2
pg/mL) in the CG, p=0.373 (Figure 3). Similarly, we repeated
the analysis after removing cases with neonatal birthweight
o10th percentile and demonstrated the same statistical
findings for IL-10 (10.7 vs 22.1, p=0.017), IL-12 (88.3 vs.
73.1, p=0.487) and IL-15 (7.5 vs. 15.0, p=0.027).
’ DISCUSSION
The findings of the present study show that twin preg-
nancies with PE had higher placental expression of IL-15 and
higher maternal serum levels of IL-10 and IL-15 than those in
the CG.
Although the complete pathophysiology of PE has not
yet been elucidated, it is well known that the maternal-fetal
placental interface plays an important role (5). Therefore,
attention should be concentrated on the predominant cell
types present in this region, such as dNK cells. However,
even in singleton gestations, there is still no consensus in
the literature concerning dNK decidual expression in PE
(9,11,25). Consistent with the results demonstrated by Eide
et al. (13), in the present study, we did not observe a difference
in dNK placental expression between the groups. These
findings may suggest a greater physiological importance of
dNK cell function and molecular interaction rather than their
numerical expression.
Concerning dNK regulatory cytokines, we observed higher
maternal serum levels of both anti- and pro-inflammatory
interleukins (IL-10 and IL-15, respectively) in the PEG. How-
ever, this balance was not sustained in the placental histo-
logical analysis; we noticed higher expression of the inflam-
matory IL-15 in the PEG and no difference between the
groups in decidual expression of IL-10 and IL-12. In contrast,
the only previous study involving placental analysis of IL-15
in PE demonstrated unchanged levels of this factor in patients
with the disease (10). For the other factors, a few studies have
observed lower decidual expression of IL-10 and IL-12 in
singleton pregnancies with PE (9,10,18).
PE is associated with chronic immune activation, leading
to elevated serum levels of inflammatory cytokines. These
increased levels of IL-15 may contribute to endothelial
dysfunction during PE (5). Additionally, IL-15 may stimulate
the production of IFN-g, a substance with deleterious effects
on trophoblastic invasion (26).
Considering PE as a pro-inflammatory state, we can
hypothesize that our findings of higher serum levels of both
IL-10 and IL-15 may correspond to a maternal response
represented by anti-inflammatory feedback. In addition, the
absence of a significant difference between the groups in
placental expression of IL-10 suggests that the maternal effort
to balance pro- and anti-inflammatory responses occurs only
at the serum level, with no impact in the decidual region,
which may contribute to the development of the disease
in PEG.
The main limitation of this study was the small number of
cases, which was mainly related to the single-center nature
of the analysis and the inclusion of only pure PE cases;
therefore, multicenter studies may be necessary to confirm
our findings. Notwithstanding, this was the first study that
specifically analyzed the expression of dNK cells and their
regulatory interleukins in twin pregnancies with PE. Further-
more, our findings may provide insights into possible immune
mechanisms involved in the pathophysiology of PE.
Figure 3 - Maternal serum levels of regulatory dNK interleukins.
Data described as the median (range), values in pg/ml. IL =
interleukin. Mann-Whitney test, po0.05.
Figure 2 - Immunohistochemical expression of dNK cells and their
regulatory interleukins in placental decidua. Antibodies anti-
CD56, anti-IL-10, anti-IL-12p40 and anti-IL-15 were used. One
representative case of each group is presented.
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